AMFI - Registered Mutual Fund Distributor

Corona Remedies Limited IPO

Corona Remedies Limited IPO

₹ 14868 / 14 Shares Shares
Minimum Investment

Corona Remedies Limited IPO

Issues Price

₹1008-1062 per equity share

Corona Remedies Limited IPO

Open Date

08 Dec 2025

Close Date

10 Dec 2025

Lot Size

14

Min. Investment

₹ 14868

Issue Price

₹1008-1062

Listing Date

15 Dec 2025

Issues Size

61,71,101 shares(aggregating up to ₹655.37 crore)

Face Value

₹10 Per Equity Share

Total Shares Offered

14 Shares

Offered To Public

14 Shares

Corona Remedies Limited IPO

Incorporated in August 2004, Corona Remedies Limited is a pharmaceutical company developing, manufacturing, and marketing products in women's healthcare, cardiology, pain management, urology, and other therapeutic areas. The diversified portfolio of the company as of December 2024 comprises 67 brands across therapeutic areas such as women's healthcare, cardio-diabeto, pain management, urology, and multispecialty pharmaceuticals, including vitamins/minerals/nutrition, gastrointestinal, and respiratory.The company has a pan-India marketing and distribution network with 2,598 medical representatives in 22 states, enabling effective engagement with healthcare professionals and hospitals, thus consolidating its presence in the IPM and ensuring deep penetration in therapeutic areas. Presently, the company owns two manufacturing facilities located in the states of Gujarat. As of December 31, 2024, the company had 88 R&D employees.

Founded In

2004

Managing Director

Dr. Kirtikumar Laxmidas Mehta

Parent Organization

Corona Remedies Limited IPO

Application Details of Corona Remedies Limited IPO.

Apply as Price Range Apply Upto
Retail (min) ₹1008-1062 ₹14,868
Retail(max) ₹1008-1062 ₹1,93,284
SHNI(min) ₹1008-1062 ₹2,08,152
SHNI(max) ₹1008-1062 ₹9,96,156
BHNI(min) ₹1008-1062 ₹10,11,024

For Corona Remedies Limited IPO, eligible investors can apply as Regular.

ksquare

Open On12 Dec 2025

Close On16 Dec 2025

Price Range₹2061-2165

ksquare

Open On15 Dec 2025

Close On17 Dec 2025

Price Range₹126

ksquare

Open On12 Dec 2025

Close On16 Dec 2025

Price Range₹135-142

ksquare

Open On11 Dec 2025

Close On15 Dec 2025

Price Range₹94-96

ksquare

Open On11 Dec 2025

Close On15 Dec 2025

Price Range₹112-118

ksquare

Open On10 Dec 2025

Close On12 Dec 2025

Price Range₹12


Testimonial

Genuine Review Form Statisifed Customers

4.6 Out of 5 (6129 Reviews)

KSquare’s NPS support was practical and transparent. They helped me compare options and choose what’s best for my future.

Naveen Thakkar

Naveen Thakkar

Chartered Accountant

KSquare helped me discover exciting new funds through their launch calendar. I love how quick and responsive their team is whenever I have queries.

Shanaya Bhatt

Shanaya Bhatt

Fashion Consultant

Managing money in India while living overseas used to be stressful. KSquare’s platform made everything manageable and safe.

Karan Patel

Karan Patel

Legal Consultant

KSquare’s SIP plans align perfectly with my monthly savings goals. I appreciate how effortless the process is. It's really helped me become financially disciplined.

Ananya Joshi

Ananya Joshi

Interior Designer

Investing in India felt intimidating until I found KSquare. Their NRI Corner made it straightforward and transparent. It’s exactly what I needed living abroad.

Divya Bhatia

Divya Bhatia

University Lecturer

KSquare provides a transparent and smooth mutual fund experience. Their portfolio tools are user-friendly, and I love how effortless it feels to invest monthly.

Ritesh Bansal

Ritesh Bansal

Mechanical Engineer

I was looking for a secure retirement plan, and KSquare’s NPS guidance made it very easy to start.

Richa Mahajan

Richa Mahajan

HR Advisor

Living overseas, I struggled with Indian investments. KSquare’s NRI Corner fixed that. Their expert advice and ease of access gave me complete peace of mind.

Sneha Kulkarni

Sneha Kulkarni

Healthcare Administrator

KSquare helped me invest in Indian markets with zero stress. Their NRI Corner is truly designed for people living abroad.

Ira D’Souza

Ira D’Souza

Startup Advisor

KSquare made my NPS journey easy. Their guidance and clear comparison of schemes helped me confidently plan for retirement. I highly recommend their personalized pension support.

Aakash Mehta

Aakash Mehta

Civil Engineer

FAQ's

Frequenlty Asked Question

What is the minimum investment for NPS?

You can start your NPS investment with as little as ₹500 for Tier I and ₹1,000 for Tier II accounts.

Does KSquare offer customer support for NRIs in different time zones?

Yes, KSquare provides responsive support and scheduling flexibility for NRIs in all global time zones.

What is the minimum amount required to start a SIP?

You can begin a SIP with as little as ₹500 per month, making it accessible for investors of all income levels.

Can I repatriate funds from my investments through KSquare?

Repatriation is allowed from NRE accounts. Investments via NRO are non-repatriable beyond set RBI limits.

What documents are required to invest in mutual funds via KSquare?

You need a PAN card, Aadhaar, bank details, and address proof for KYC verification before starting investments.

Can I increase my SIP amount later?

Yes, KSquare allows you to modify or increase your SIP contributions easily as your income or goals change.

Is there any penalty for missing a SIP installment?

No penalties are charged by mutual funds for missing SIPs, but your bank may charge ECS failure fees if funds are insufficient.

Are returns from mutual funds taxable for NRIs?

Yes, returns are subject to TDS based on fund type and holding period. KSquare helps you plan for this.

App Store

Ksquare Timeline Pvt. Ltd. is an AMFI Registered Mutual Fund Distributor having ARN No. 146262. Mutual Fund investments are subject to market risks. Please read all scheme related documents carefully before investing. This website is intended only for informational and self-help purposes and should not be considered as investment advice or return guarantee. Past performance is not indicative of future results. Terms & Conditions apply.